Immunohistochemical expression of the cyclooxygenase-2 (COX-2) in gastric cancer. The correlations with the tumor angiogenesis and patients' survival

Romanian Journal of Morphology and Embryology

Volumn 49, Issue 3, 2008, Pages 371-379

  Lazǎr, Daniela ^a   Tǎban, Sorina ^a   Ardeleanu, Carmen ^b   Simionescu, Cristiana ^c   Sporea, I ^a   Cornianu, Marioara ^a   Vernic, Corina ^a  

^a VICTOR BABES UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^b NATIONAL INSTITUTE FOR RESEARCH AND DEVELOPMENT IN MICROTECHNOLOGIES   (Romania)

^c UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA   (Romania)

Author keywords

COX 2; Gastric cancer; Survival; Tumor angiogenesis

Indexed keywords

CYCLOOXYGENASE 2; PTGS2 PROTEIN, HUMAN; UNCLASSIFIED DRUG; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; CARCINOMA; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; METABOLISM; MIDDLE AGED; MORTALITY; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; STOMACH TUMOR; SURVIVAL; VASCULARIZATION;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CYCLOOXYGENASE 2; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 58149199147     PISSN: 12200522     EISSN: 20668279     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Williams C. S., DuBois R. N., Prostaglandin endoperoxide synthase: why two isoforms?, Am J Physiol, 1996, 270(3 Pt 1):G393-400.
2. Sheng H., Shao J., Dixon D. A., Williams C. S., Prescott S. M., DuBois R. N., Beauchamp R. D., Transforming growth factor-β1 enhances Ha-ras-induced expression of cyclooxygenase-2 in intestinal epithelial cells via stabilization of mRNA, J Biol Chem, 2000, 275(9):6628-6635.
3. Ramsay R. G., Friend A., Vizantios Y., Freeman R., Sicurella C., Hammett F., Armes J., Venter D., Cyclooxygenase-2, a colorectal cancer nonsteroidal anti-inflammatory drug target, is regulated by c-MYB, Cancer Res, 2000, 60(7):1805-1809.
4. De Lorenzo M. S., Yamaguchi K., Subbaramaiah K., Dannenberg A. J., Bryostatin-1 stimulates the transcription of cyclooxygenase-2: evidence for an activator protein-1-dependent mechanism, Clin Cancer Res, 2003, 9(13):5036-5043.
5. Jung Y. J., Isaacs J. S., Lee S., Trepel J., Neckers L., IL-1beta-mediated up-regulation of HIF-1alpha via an NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis, FASEB J, 2003, 17(14):2115-2117.
6. Taketo M. M., Cyclooxygenase-2 inhibitors in tumorigenesis (Part II), J Natl Cancer Inst, 1998, 90(21):1609-1620.
7. Dannenberg A. J., Altorki N. K., Boyle J. O., Dang C., Howe L. R., Weksler B. B., Subbaramaiah K., Cyclooxygenase-2: a pharmacological target for the prevention of cancer, Lancet Oncol, 2001, 2(9):544-551.
8. Gupta R. A., Dubois R. N., Colorectal cancer prevention and treatment by inhibition of cyclooxygenase-2, Nat Rev Cancer, 2001, 1(1):11-21.
9. Van Rees B. P., Ristimäki A., Cyclooxygenase-2 in carcinogenesis of the gastrointestinal tract, Scand J Gastroenterol, 2001, 36(9):897-903.
10. Gately S., The contributions of cyclooxygenase-2 to tumor angiogenesis, Cancer Metastasis Rev, 2000, 19(1-2):19-27.
11. Saukkonen K., Rintahaka J., Sivula A., Buskens C. J., Van Rees B. P., Rio M. C., Haglund C., Van Lanschot J. J, Offerhaus G. J., Ristimäki A., Cyclooxygenase-2 and gastric carcinogenesis, APMIS, 2003, 111(10):915-925.
12. Ratnasinghe D., Tangrea J. A., Roth M. J., Dawsey S. M., Anver M., Kasprzak B. A., Hu N., Wang Q. H., Taylor P. R., Expression of cyclooxygenase-2 in human adenocarcinomas of the gastric cardia and corpus, Oncol Rep, 1999, 6(5):965-968.
13. Lim H. Y., Joo H. J., Choi J. H., Yi J. W., Yang M. S., Cho D. Y., Kim H. S., Nam D. K., Lee K. B., Kim H. C., Increased expression of cyclooxygenase-2 protein in human gastric carcinoma, Clin Cancer Res, 2000, 6(2):519-525.
14. Sung J. J., Leung W. K., Go M. Y., To K. F., Cheng A. S., Ng E. K., Chan F. K., Cyclooxygenase-2 expression in Helicobacter pylori-associated premalignant and malignant gastric lesions, Am J Pathol, 2000, 157(3):729-735.
15. Chen C. N., Sung C. T., Lin M. T., Lee P. H., Chang K. J., Clinicopathologic association of cyclooxygenase 1 and cyclooxygenase 2 expression in gastric adenocarcinoma, Ann Surg, 2001, 233(2):183-188.
16. Lee T. L., Leung W. K., Lau J. Y., Tong J. H., Ng E. K., Chan F. K., Chung S. C., Sung J. J., To K. F., Inverse association between cyclooxygenase-2 overexpression and microsatellite instability in gastric cancer, Cancer Lett, 2001, 168(2):133-140.
17. Leung W. K., To K. F., Ng Y. P., Lee T. L., Lau J. Y., Chan F. K., Ng E. K., Chung S. C., Sung J. J., Association between cyclooxygenase-2 overexpression and missense p53 mutations in gastric cancer, Br J Cancer, 2001, 84(3):335-339.
18. Rajnakova A., Moochhala S., Goh P. M., Ngoi S., Expression of nitric oxide synthase, cyclooxygenase and p53 in different stages of human gastric cancer, Cancer Lett, 2001, 172(2):177-185.
19. Saukkonen K., Nieminen O., van Rees B., Vilkki S., Härkönen M., Juhola M., Mecklin J. P., Sipponen P., Ristimäki A., Expression of cyclooxygenase-2 in dysplasia of the stomach and in intestinal-type gastric adenocarcinoma, Clin Cancer Res, 2001, 7(7):1923-1931.
20. Joo Y. E., Oh W. T., Rew J. S., Park C. S., Choi S. K., Kim S. J., Cyclooxygenase-2 expression is associated with well-differentiated and intestinal-type pathways in gastric carcinogenesis, Digestion, 2002, 66(4):222-229.
21. Kawabe A., Shimada Y., Uchida S., Maeda M., Yamasaki S., Kato M., Hashimoto Y., Ohshio G., Matsumoto M., Imamura M., Expression of cyclooxygenase-2 in primary and remnant gastric carcinoma: comparing it with p53 accumulation, Helicobacter pylori infection and vascular endothelial growth factor expression, J Surg Oncol, 2002, 80(2):79-88.
22. Yamagata R., Shimoyama T., Fukuda S., Yoshimura T., Tanaka M., Munakata A., Cyclooxygenase-2 expression is increased in early intestinal-type gastric cancer and gastric mucosa with intestinal metaplasia, Eur J Gastroenterol Hepatol, 2002, 14(4):359-363.
23. Ohno R., Yoshinaga K., Fujita T., Hasegawa K., Iseki H., Tsunozaki H., Ichikawa W., Nihei Z., Sugihara K., Depth of invasion parallels increased cyclooxygenase-2 levels in patients with gastric carcinoma, Cancer, 2001, 91(10):1876-1881.
24. Uefuji K., Ichikura T., Mochizuki H., Shinomiya N., Expression of cyclooxygenase-2 protein in gastric adenocarcinoma, J Surg Oncol, 1998, 69(3):168-172.
25. Sun W. H., Sun Y. L., Fang R. N., Shao Y., Xu H. C., Xue Q. P., Ding G. X., Cheng Y. L., Expression of cyclooxygenase-2 and matrix metalloproteinase-9 in gastric carcinoma and its correlation with angiogenesis, Jpn J Clin Oncol, 2005, 35(12):707-713.
26. Van Rees B. P., Saukkonen K., Ristimäki A., Polkowski W, Tytgat G. N., Drillenburg P., Offerhaus G. J., Cyclooxygenase-2 expression during carcinogenesis in the human stomach, J Pathol, 2002, 196(2):171-179.
27. Ristimäki A., Honkanen N., Jänkälä H., Sipponen P., Härkönen M., Expression of cyclooxygenase-2 in human gastric carcinoma, Cancer Res, 1997, 57(7):1276-1280.
28. Murata H., Kawano S., Tsuji S., Tsuji M., Sawaoka H., Kimura Y., Shiozaki H., Hori M., Cyclooxygenase-2 overexpression enhances lymphatic invasion and metastasis in human gastric carcinoma, Am J Gastroenterol, 1999, 94(2):451-455.
29. Xue Y. W., Zhang Q. F., Zhu Z. B., Wang Q., Fu S. B., Expression of cyclooxygenase-2 and clinicopathologic features in human gastric adenocarcinoma, World J Gastroenterol, 2003, 9(2):250-253.
30. Lim H. Y., Joo H. J., Choi J. H., Yi J. W., Yang M. S., Cho D. Y, Kim H. S, Nam D. K, Lee K. B, Kim H. C, Increased expression of cyclooxygenase-2 protein in human gastric carcinoma, Clin Cancer Res, 2000, 6(2):519-525.
31. Han S. L., Tang H. J., Hua Y. W., Ji S. Q., Lin D. X., Expression of COX-2 in stomach cancers and its relation to their biological features, Dig Surg, 2003, 20(2):107-114.
32. Mrena J., Wiksten J. P., Thiel A., Kokkola A., Pohjola L., Lundin J., Nordling S., Ristimäki A., Haglund C., Cyclooxygenase-2 is an independent prognostic factor in gastric cancer and its expression is regulated by the messenger RNA stability factor HuR, Clin Cancer Res, 2005, 11(20):7362-7368.
33. Joo Y. E., Rew J. S., Seo Y. H., Choi S. K., Kim Y. J., Park C. S., Kim S. J., Cyclooxygenase-2 overexpression correlates with vascular endothelial growth factor expression and tumor angiogenesis in gastric cancer, J Clin Gastroenterol, 2003, 37(1):28-33.
34. Li H. X., Chang X. M., Song Z. J., He S. X., Correlation between expression of cyclooxygenase-2 and angiogenesis in human gastric adenocarcinoma, World J Gastroenterol, 2003, 9(4):674-677.
35. Yu H. G., Li J. Y., Yang Y. N., Luo H. S., Yu J. P., Meier J. J., Schrader H., Bastian A., Schmidt W. E., Schmitz F., Increased abundance of cyclooxygenase-2 correlates with vascular endothelial growth factor-A abundance and tumor angiogenesis in gastric cancer, Cancer Lett, 2003, 195(1):43-51.
36. Shi H., Xu J. M., Hu N. Z., Xie H. J., Prognostic significance of expression of cyclooxygenase-2 and vascular endothelial growth factor in human gastric carcinoma, World J Gastroenterol, 2003, 9(7):1421-1426.
37. Tatsuguchi A., Matsui K., Shinji Y., Gudis K., Tsukui T., Kishida T., Fukuda Y., Sugisaki Y., Tokunaga A., Tajiri T., Sakamoto C., Cyclooxygenase-2 expression correlates with angiogenesis and apoptosis in gastric cancer tissue, Hum Pathol, 2004, 35(4):488-495.
38. Buskens C. J., Sivula A., van Rees B. P., Haglund C., Offerhaus G. J. A., van Lanschot J. J. B., Ristimäki A., Comparison of cyclooxygenase 2 expression in adenocarcinomas of the gastric cardia and distal oesophagus, Gut, 2003, 52(12):1678-1683.
39. Fosslien E., Review: molecular pathology of cyclooxygenase-2 in cancer-induced angiogenesis, Ann Clin Lab Sci, 2001, 31(4):325-348.
40. Langman M. J. S., Cheng K. K., Gilman E. A., Lancashire R. J., Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database, BMJ, 2000, 320(7250):1642-1646.
41. Akre K., Ekström A. M., Signorello L. B., Hansson L. E., Nyrén O., Aspirin and risk of gastric cancer: a populationbased case-control study in Sweden, Br J Cancer, 2001, 84(7):965-968.
42. Masferrer J. L., Leahy K. M., Koki A. T., Zweifel B. S., Settle S. L., Woerner B. M., Edwards D. A., Flickinger A. G., Moore R. J., Seibert K., Antiangiogenic and antitumor activities of cyclooxygenase-2 inhibitors, Cancer Res, 2000, 60(5):1306-1311.
43. Jones M. K., Wang H., Peskar B. M., Levin E., Itani R. M., Sarfeh I. J., Tarnawski A. S., Inhibition of angiogenesis by nonsteroidal anti-inflammatory drugs: insight into mechanisms and implications for cancer growth and ulcer healing, Nat Med, 1999, 5(12):1418-1423.
44. Saukkonen K., Tomasetto C., Narko K., Rio M. C., Ristimäki A., Cyclooxygenase-2 expression and effect of celecoxib in gastric adenomas of trefoil factor 1-deficient mice, Cancer Res, 2003, 63(12):3032-3036.
45. Torrance C. J., Jackson P. E., Montgomery E., Kinzler K. W., Vogelstein B., Wissner A., Nunes M., Frost P., Discafani C. M., Combinatorial chemoprevention of intestinal neoplasia, Nat Med, 2000, 6(9):1024-1028.
46. Mann M., Sheng H., Shao J., Williams C. S., Pisacane P. I., Sliwkowski M. X., DuBois R. N., Targeting cyclooxygenase 2 and HER-2/neu pathways inhibits colorectal carcinoma growth, Gastroenterology, 2001, 120(7):1713-1719.
47. Fosslien E., Biochemistry of cyclooxygenase (COX)-2 inhibitors and molecular pathology of COX-2 in neoplasia, Crit Rev Clin Lab Sci, 2000, 37(5):431-502.